FDA approves Merck lung disease drug acquired in $11B deal
Bio Pharma Dive
MARCH 26, 2024
Merck is couting on Winrevair, which it acquired by buying Acceleron Pharma, to help soften the blow when Keytruda loses patent protection later this decade.
Let's personalize your content